One More Reason Halfway Socialized Healthcare is the Worst

A few years ago, a company called Genentech developed a cancer treatment it called Avastin. Avastin was a very expensive and dubiously effective cancer treatment, but it turned out to be great at treating Wet Age-Related Macular Degeneration—an eye disease that causes blindness in older patients. Another plus—an extraordinarily small dose of Avastin was sufficient […]

Continue reading →